"Many patients are initially misdiagnosed with other disorders such as Lambert-Eaton myasthenic syndrome, stroke, multiple sclerosis, or psychiatric conditions." ...

Introduction Lambert–Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of the presynaptic neuromuscular junction associated with antibody mediated dysfunction of the alpha 1A subunit of the ...

A medical expert discusses the key aspects of Lambert-Eaton Myasthenic Syndrome (LEMS) in the context of small cell lung cancer (SCLC), including its differential diagnosis, long-term effects ...

What is Lambert-Eaton syndrome? Lambert-Eaton syndrome is also known as Lambert-Eaton myasthenic syndrome. It is a rare, autoimmune disorder in which the immune system attacks the neuromuscular ...

Lambert-Eaton myasthenic syndrome is extremely rare, with a global prevalence of only 2.8 per million, and just 400 known cases in the US.

Up to 100mg daily in divided doses was administered to patients in the expanded access program.

The FDA approved Catalyst Pharmaceuticals' supplemental New Drug Application (sNDA) for an increased daily dose of amifampridine (Firdapse) for both adults and pediatric patients with Lambert-Eaton ...

Clinical outcomes, demographics and associative analysis of lung cancer patients with Lambert-Eaton myasthenic syndrome: Insights from the National Inpatient Sample (NIS) database.. If you have the ...

Myasthenia gravis (MG) and Lambert-Eaton syndrome, also known as Lambert-Eaton myasthenic syndrome (LEMS), are two autoimmune disorders that attack your muscles.